Takeda.com - SEO Checker

Sign up for free! PDF Export
Overview of the SEO Check
Meta information
100% 
Page quality
82% 
Page structure
100% 
Link structure
67% 
Server
91% 
External factors
100% 
SEO Score
Response time
0.28 s
File size
293.60 kB
Words
507
Media files
6
Number of links
91 internal / 2 external

Task list of SEO Improvements

Meta specifications

Title
(Critically important)
Takeda Pharmaceuticals: Global Homepage
The length of the page title is perfect. (394 pixels out of 580 max pixel length)
There are no duplicate words in the title
Meta description
(Critically important)
Takeda is a patient-focused, R&D-driven global biopharmaceutical company committed to bringing Better Health and a Brighter Future.
The length of the meta description is perfect. (830 pixels out of 1000 max pixel length)
Crawlability
(Critically important)
There are no problems in accessing the website.
Canonical URL
(Important)
https://www.takeda.com/
There is a valid canonical link specified.
Language
(Somewhat important)
Language detected in text: en
Language defined in HTML: en
Server location: United States of America
The following language is defined by HTML: en
Alternate/Hreflang Links
(Somewhat important)
The specified alternate links have no errors.
Other meta tags
(Somewhat important)
There is no rel next meta tag on this page.
There is no rel prev meta tag on this page.
Domain
(Somewhat important)
The domain is no subdomain.
The domain length is good.
The domain does not contain non-latin characters.
Page URL
(Somewhat important)
No parameters were found in the URL.
No session ID was found in the URL.
The URL does not have too many subdirectories.
Charset encoding
(Somewhat important)
The charset encoding (UTF-8) is set correctly.
Doctype
(Nice to have)
The doctype HTML 5 is set correctly.
The doctype is placed at first in the HTML code.
Favicon
(Nice to have)
The favicon is linked correctly.

Meta tags

NameValue
viewportuser-scalable=yes, width=device-width, initial-scale=1, maximum-scale=2, viewport-fit=cover
robotsindex,follow
descriptionTakeda is a patient-focused, R&D-driven global biopharmaceutical company committed to bringing Better Health and a Brighter Future.
next-head-count39
langen
twitter:cardsummary_large_image
og:titleTakeda Pharmaceuticals: Global Homepage
og:descriptionTakeda is a patient-focused, R&D-driven global biopharmaceutical company committed to bringing Better Health and a Brighter Future.
og:urlhttps://www.takeda.com/
og:imagehttp://assets-dam.takeda.com/image/upload/v1683892920/Global/OG%20Logo.jpg
og:image:altTakeda Pharmaceuticals: Global Homepage
og:image:secure_urlhttps://assets-dam.takeda.com/image/upload/v1683892920/Global/OG%20Logo.jpg
og:image:typeimage
og:image:width1200
og:image:height627
og:localeen
charsetutf-8

Test up to 1.000 webpages of takeda.com with our free plan!

Try For Free
No trial. It's just free!

Page quality

Content
(Critically important)
Words from the H1 heading are not used in the page content.
This page contains 507 words. That's ok.
24.9% of the text are stop words.
Keywords used in the page title are also used in the page content. That's good!
The page contains a listing, which indicates a good text layout.
7 paragraphs were found on this page.
No placeholders texts or images were found.
There are no duplicates on the site.
The average number of words per sentence of 17.88 words is good.
Frames
(Critically important)
This page does not use a frameset.
Mobile optimization
(Somewhat important)
A viewport "user-scalable=yes, width=device-width, initial-scale=1, maximum-scale=2, viewport-fit=cover" is provided.
At least one Apple touch icon is specified.
Bold and strong tags
(Somewhat important)
The following tag is repeated too often: find out more
Image SEO
(Somewhat important)
Alt text (alternative text) is correctly used on all found images.
Social Networks
(Nice to have)
There are only a few social sharing widgets on the page. Make your website popular in social networks with social sharing widgets.
Additional markup
(Nice to have)
No additional page markup was found.
HTTPS
(Somewhat important)
This website uses HTTPS to protect privacy and integrity of the exchanged data.
All included files are also transferred via HTTPS.

Media list

URLAlt attributeTitle
...054162cb1dd2807ef9d39eee5effe406-720x257Takeda logo
...FY2024-global-CSR-partners/Health_workerDoctor interviewing a patient
...siteassets/system/careers/careers-bannertwo women in a laboratory
...:eco/f_auto/v1/Global/Investor/InvestorsPeople shaking hands in office
...Research and Development/R_D_home_cf7hxlman in labcoat
...054162cb1dd2807ef9d39eee5effe406-720x257Takeda logo

Page structure

H1 heading
(Critically important)
Takeda Pharmaceuticals: Global Homepage
The H1 heading is perfect.
Headings
(Important)
The heading structure is perfect.

Heading structure

Heading levelContent
H1 Takeda Pharmaceuticals: Global Homepage
H2 From the heart: Meet our 2024 global CSR partners
H2 Recent News
H2 Better Health, Brighter Future
H2 Our Areas of Focus
H2 Sign up for investors newsletter
H3 Takeda to Present Additional Clinical Trial Study Data Highlighting the Impact of Orexin Agonist TAK-861 on the Burden of Narcolepsy at Sleep Europe 2024
H3 Takeda Commits Over $32 Million in Five New Global Corporate Social Responsibility Partnerships To Further Drive Health Impact in 93 Countries
H3 Takeda Receives European Commission Approval for ADZYNMA®▼ (Recombinant ADAMTS13) as the First and Only Recombinant ADAMTS13 Replacement Therapy for Congenital Thrombotic Thrombocytopenic Purpura (...
H3 Takeda Announces First Quarter FY2024 Results – Strong Performance by Growth & Launch Products; Advancements in Promising Late-Stage Pipeline
H3 Join Us
H3 Investors
H3 R&D
H3 Gastrointestinal and Inflammation
H3 Rare Diseases
H3 Plasma-Derived Therapies
H3 Oncology
H3 Neuroscience
H3 Vaccines
Some internal link anchor texts are too long.
Some anchor texts are used more than once.
The number of internal links is ok.
All internal links are not using dynamic parameters.
There are 2 external links on this page.

Found links on this page

LinkAttributesAnchor text
https://www.takeda.com/IMG-ALT Takeda logo
/about/our-company/Our Company
/about/leadership/Leadership
/about/corporate-responsibilit...Sustainability Approach
/about/corporate-responsibilit...Access to Medicines
/about/corporate-responsibilit...Sustainability Disclosures
/about/corporate-responsibilit...Ethics
/about/corporate-responsibilit...Transparency Disclosures
/about/corporate-responsibilit...Positions
/about/corporate-responsibilit...Corporate Giving
/about/corporate-governance/st...Governance Strategy
/about/corporate-governance/go...Governance Structure
/about/corporate-governance/ch...Charters and Reports
/science/areas-of-focus/Areas of Focus
/science/research-and-developm...Research and Development
/science/pipeline/Pipeline
/science/products/Our Products
/science/products/manufacturing/Manufacturing
/science/products/suppliers/Suppliers
/science/clinical-trials/Clinical Trials
/our-impact/our-stories/Our Stories
/newsroom/press-releases/Press Releases
/newsroom/statements/Statements
/newsroom/media-resources/Media Resources
/investors/overview/Overview
/investors/financial-results/q...Financial Results
/investors/events/Investor Events
/investors/contact/Investor Contact
https://www.takeda.com/careers/Careers
/about/our-company/Text duplicate Our Company
/about/leadershipText duplicate Leadership
/about/corporate-responsibilit...Text duplicate Sustainability Approach
/about/corporate-responsibilit...Text duplicate Access to Medicines
/about/corporate-responsibilit...Text duplicate Sustainability Disclosures
/about/corporate-responsibilit...Text duplicate Ethics
/about/corporate-responsibilit...Text duplicate Transparency Disclosures
/about/corporate-responsibilit...Text duplicate Positions
/about/corporate-responsibilit...Text duplicate Corporate Giving
/about/corporate-governance/st...Text duplicate Governance Strategy
/about/corporate-governance/go...Text duplicate Governance Structure
/about/corporate-governance/ch...Text duplicate Charters and Reports
/science/areas-of-focus/Text duplicate Areas of Focus
/science/research-and-developmentText duplicate Research and Development
/science/pipelineText duplicate Pipeline
/science/productsText duplicate Our Products
/science/products/manufacturingText duplicate Manufacturing
/science/products/suppliersText duplicate Suppliers
/science/clinical-trialsText duplicate Clinical Trials
/our-impact/our-storiesText duplicate Our Stories
/newsroom/press-releasesText duplicate Press Releases
/newsroom/statementsText duplicate Statements
/newsroom/media-resourcesText duplicate Media Resources
/investors/overviewText duplicate Overview
/investors/financial-results/q...Text duplicate Financial Results
/investors/eventsText duplicate Investor Events
/investors/contactText duplicate Investor Contact
https://www.takeda.com/careersText duplicate Careers
/our-impact/our-stories/meet-o...Learn More
/newsroom/newsreleases/2024/ta...Takeda to Present Additional Clinical Trial Study Data Highlighting the Impact of Orexin Agonist TAK-861 on the Burden of Narcolepsy at Sleep Europe 2024 Sep...
/newsroom/newsreleases/2024/ta...Takeda Commits Over $32 Million in Five New Global Corporate Social Responsibility Partnerships To Further Drive Health Impact in 93 Countries September 18, ...
/newsroom/newsreleases/2024/eu...Takeda Receives European Commission Approval for ADZYNMA®▼ (Recombinant ADAMTS13) as the First and Only Recombinant ADAMTS13 Replacement Therapy for Congenit...
/newsroom/newsreleases/2024/ta...Takeda Announces First Quarter FY2024 Results – Strong Performance by Growth & Launch Products; Advancements in Promising Late-Stage Pipeline July 31, 2024
/newsroom/press-releasesView All
https://www.takeda.com/careers/IMG-ALT two women in a laboratory
https://www.takeda.com/careers/Join Us
https://www.takeda.com/careers/FIND OUT MORE
/investors/overview/IMG-ALT People shaking hands in office
/investors/overview/Investors
/investors/overview/Text duplicate FIND OUT MORE
/science/research-and-developm...IMG-ALT man in labcoat
/science/research-and-developm...R&D
/science/research-and-developm...Text duplicate FIND OUT MORE
/science/areas-of-focus/gastro...Gastrointestinal and Inflammation Understanding and addressing life-limiting gastrointestinal and inflammatory diseases
/science/areas-of-focus/rare-d...Rare Diseases Working to transform treatments in immunology, hematology, metabolic and lysosomal storage disorders
/science/areas-of-focus/pdt/Plasma-Derived Therapies Improving the lives of patients with rare and complex chronic diseases through innovation in plasma
/science/areas-of-focus/oncology/Oncology Aspiring to cure cancer, with inspiration from patients and innovation from everywhere
/science/areas-of-focus/neuros...Neuroscience Driving medical innovation for patients with neurological diseases
/science/areas-of-focus/vaccines/Vaccines Addressing unmet global health needs through vaccine development against infectious diseases
/investors/newsletter/Sign up
https://www.takeda.com/Text duplicate IMG-ALT Takeda logo
https://www.linkedin.com/compa...New window External Subdomain No Text
https://www.youtube.com/takeda...New window External Subdomain No Text
https://www.takeda.com/worldwide/Locations
/contact-us/Contact us
https://www.takeda.com/careers/Text duplicate Careers
/investors/financial-highlights/Financial Highlights
https://www.takeda.com/hcps/HCPs
https://www.takeda.com/patients/Patients
https://www.takeda.com/worldwide/country selector
/terms-and-conditions/Terms and Conditions
/privacy-notice/Privacy Notice
/cookie-policy/Cookie Policy
/global-accessibility-statement/Accessibility Statement

Server configuration

HTTP redirects
(Critically important)
This page redirects to "https://www.takeda.com/"
HTTP header
(Important)
The X-powered header is sent within the response header. (unnecessary)
This page uses GZip for compressed data transmission.
Performance
(Somewhat important)
The page response time is excellent with 0.28 seconds.
The file size of the HTML document is fine (294 kB).

HTTP Response Header

NameValue
dateTue, 24 Sep 2024 02:05:21 GMT
content-typetext/html; charset=utf-8
cf-ray8c7f35841b6b2c4f-FRA
cf-cache-statusDYNAMIC
age183
cache-controlpublic, max-age=0, must-revalidate
strict-transport-securitymax-age=63072000
x-matched-path/en
x-powered-byNext.js
x-vercel-cacheHIT
x-vercel-idfra1::iad1::pdbqr-1727143521971-97f8b1ff364b
set-cookie259 Characters
varyAccept-Encoding
servercloudflare
content-encodinggzip
statuscode200
http_versionHTTP/2

External factors

This page is referenced by wikipedia.
This website has excellent links from other websites.
This page has backlinks from 11,506 referring domains.
This page has 2,167,638 backlinks.
This page has backlinks from 6,866 different ip addresses.

Links from Wikipedia

You can find more links using Wikipedia search

Robots.txt

# *
User-agent: *
Disallow: /*?
Disallow: /search?query=*
Disallow: /elmah.axd
Disallow: /admui/
Disallow: /util/
Disallow: /pingfederate
Disallow: /pingfederate/
Disallow: /ja-jp/research-support/
Disallow: /ja-jp/educational-support/
Disallow: /en-gb/hcps/privacy/
Disallow: /en-gb/hcps//subscribed/
Disallow: /en-ie/hcps/privacy/
Disallow: /en-ie/hcps/subscribed/
Disallow: /siteassets/system/privacy-notice/takedaprivacynotice_en.pdf
Disallow: /siteassets/es-es/home/what-we-do/transparencia/de-valor-2019/er-03185es_v2_24junio-2020def.pdf
Disallow: /siteassets/es-es/home/what-we-do/transparencia/de-valor-2019/er-03185en_v2_24junio_2020def.pdf
Disallow: /siteassets/es-es/home/what-we-do/transparencia/shire-transparencia/reports/shire-report-spain2019-spanish.pdf
Disallow: /siteassets/es-es/home/what-we-do/transparencia/shire-transparencia/reports/shire-report-spain2019-english.pdf
Disallow: /it-it/le-nostre-storie/associazioni-di-pazienti/
Disallow: /es-es/transparencia/colaboracion-con-asociaciones-de-pacientes-shire/
Disallow: /siteassets/es-es/home/what-we-do/transparencia/colaboracion-asoc-pacientes-shire_2019.pdf
Disallow: /es-es/transparencia/colaboracion-con-asociaciones-de-pacientes-shire/colaboracion-con-asociaciones-de-pacientes-2018-shire/
Disallow: /es-es/transparencia/colaboracion-con-asociaciones-de-pacientes-shire/colaboracion-con-asociaciones-de-pacientes-2017-Shire/
Disallow: /es-es/transparencia/colaboracion-con-asociaciones-de-pacientes-shire/colaboracion-con-asociaciones-de-pacientes-2016-Shire/
Disallow: /es-es/transparencia/colaboracion-con-asociaciones-de-pacientes-shire/colaboracion-con-asociaciones-de-pacientes-2016-Baxalta/
Disallow: /es-es/transparencia/colaboracion-con-asociaciones-de-pacientes-shire/colaboracion-con-asociaciones-de-pacientes-2015-Shire/
Disallow: /es-es/transparencia/colaboracion-con-asociaciones-de-pacientes-shire/colaboracion-con-asociaciones-de-pacientes-2014-shire/
Disallow: /es-es/transparencia/colaboracion-con-asociaciones-de-pacientes-shire/colaboracion-con-asociaciones-de-pacientes-2013-shire/
Disallow: /siteassets/es-es/home/what-we-do/transparencia/Shire-transparencia/Reports/baxalta-report-spain2015-spanish.pdf
Disallow: /siteassets/es-es/home/what-we-do/transparencia/Shire-transparencia/Reports/baxalta-report-spain2016-english.pdf
Disallow: /siteassets/es-es/home/what-we-do/transparencia/Shire-transparencia/Reports/baxalta-report-spain2016-spanish.pdf
Disallow: /siteassets/es-es/home/what-we-do/transparencia/Shire-transparencia/Reports/report-spain-english.pdf
Disallow: /siteassets/es-es/home/what-we-do/transparencia/Shire-transparencia/Reports/report-spain-spanish.pdf
Disallow: /siteassets/es-es/home/what-we-do/transparencia/Shire-transparencia/Reports/shire-report-2018-spain-english.pdf
Disallow: /siteassets/es-es/home/what-we-do/transparencia/Shire-transparencia/Reports/shire-report-2018-spain-spanish.pdf
Disallow: /siteassets/es-es/home/what-we-do/transparencia/Shire-transparencia/Reports/shire-report-spain2015-english.pdf
Disallow: /siteassets/es-es/home/what-we-do/transparencia/Shire-transparencia/Reports/shire-report-spain2015-spanish.pdf
Disallow: /siteassets/es-es/home/what-we-do/transparencia/Shire-transparencia/Reports/shire-report-spain2016-english.pdf
Disallow: /siteassets/es-es/home/what-we-do/transparencia/Shire-transparencia/Reports/shire-report-spain2016-spanish.pdf
Disallow: /siteassets/it-it/home/our-stories/tranzparence/2018_shire-efpia-report_italian.pdf
Disallow: /siteassets/it-it/home/our-stories/tranzparence/2017_shire_efpia-report_italian.pdf
Disallow: /siteassets/it-it/home/our-stories/tranzparence/2016_shire_fpia-report_italian.pdf
Disallow: /siteassets/it-it/home/our-stories/tranzparence/2016_baxalta-report_italian.pdf
Disallow: /siteassets/it-it/home/our-stories/tranzparence/2015_shire_efpia-report_italian.pdf
Disallow: /en-gb/hcps/chatbot-terms
Disallow: /en-gb/hcps/chatbot-privacy-notice
Disallow: /siteassets/en-gb/home/hcps/pi/vipidia_vipdomet_pi.pdf
Disallow: /siteassets/en-gb/home/hcps/pi/replagal_pi.pdf 
Disallow: /siteassets/en-gb/home/hcps/pi/VPRIV_pi.pdf
Disallow: /siteassets/en-gb/home/hcps/pi/TAKHZYRO_pi.pdf
Disallow: /en-gb/mental-health-webinar-series-practitioner-mental-well-being/
Disallow: /siteassets/system/biolife/us-new-hire-paperwork-checklist_biolifeplasmaservices.pdf
Disallow: /siteassets/system/biolife/instructions-for-tasks-to-complete-within-24-hours_biolifeplasmaservices.pdf
Disallow: /siteassets/system/biolife/instructions-for-tasks-to-complete-within-48-hours_biolifeplasmaservices.pdf
Disallow: /siteassets/system/biolife/2020-benefits-information_biolifeplasmaservices.pdf
Disallow: /siteassets/system/biolife/douments-to-review-prior-to-start_biolifeplasmaservices.pdf
Disallow: /siteassets/en-gb/home/hcps/pi/*.pdf
Disallow: /siteassets/en-gb/home/hcps/pi/hyqvia-pi.pdf
Disallow: /siteassets/en-gb/home/hcps/pi/cuvitru-pi.pdf
Disallow: /siteassets/en-gb/home/hcps/pi/uk-prostapdcs-breast-cancer-and-ovarian.pdf
Disallow: /siteassets/en-gb/home/hcps/pi/uk-prostap-dcs-all-indications.pdf
Disallow: /siteassets/en-gb/home/hcps/pi/elaprase_pi.pdf
Disallow: /siteassets/en-gb/home/hcps/pi/cinryze-pi.pdf
Disallow: /siteassets/en-gb/home/hcps/pi/firazyr-pi.pdf
Disallow: /siteassets/en-gb/home/hcps/pi/kiovig-pi.pdf
Disallow: /siteassets/en-gb/home/hcps/pi/revestive_pi.pdf
Disallow: /siteassets/en-gb/home/hcps/pi/uk-prostap_dcs_gynaecological_indications.pdf
Disallow: /siteassets/en-gb/home/hcps/pi/uk-prostap_dcs_prostate-cancer_pi.pdf
Disallow: /en-ie/frailty-assessment-and-sequencing-in-patients-with-transplant-ineligible-multiple-myeloma-1
Disallow: /en-ie/frailty-assessment-and-sequencing-in-patients-with-transplant-ineligible-multiple-myeloma-2
Disallow: /siteassets/en-us/home/external-reference/InfluenzaConsentForm/influenza-2021-2022-consent-form-english.pdf
Disallow: /siteassets/en-us/home/external-reference/InfluenzaConsentForm/influenza-2021-2022-consent-form-spanish.pdf
Disallow: /siteassets/en-us/home/external-reference/InfluenzaConsentForm/influenza-vis-english.pdf
Disallow: /siteassets/en-us/home/external-reference/InfluenzaConsentForm/influenza-vis-spanish.pdf

# Host
Host: https://www.takeda.com

# Sitemap
Sitemap: https://www.takeda.com/sitemap.xml

Similar sites

Search preview

www.takeda.com
Takeda Pharmaceuticals: Global Homepage
Takeda is a patient-focused, R&D-driven global biopharmaceutical company committed to bringing Better Health and a Brighter Future.

Most important keywords

Following keywords were found. You can check the keyword optimization of this page for each keyword.

KeywordResultRecheck
Takeda93%Check
Global79%Check
Takeda Pharmaceuticals79%Check
Global Homepage72%Check
Global Health68%Check
Pharmaceuticals62%Check
Global Corporate60%Check
Pharmaceutical Company60%Check
Health56%Check
better health54%Check
Show more keywords and terms

Test up to 1.000 webpages of takeda.com with our free plan!

Try For Free
No trial. It's just free!

Cookie Policy

We use cookies to make our site work and also for analytics and advertising purposes. You can enable or disable optional cookies as desired. See the following links for more information.

Contact | Privacy

We need these so the site can function properly

So we can better understand how visitors use our website

So we can serve you tailored ads and promotions